Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Inventory (2016 - 2019)

Ironwood Pharmaceuticals' Inventory history spans 8 years, with the latest figure at $648000.0 for Q4 2019.

  • For Q4 2019, Inventory changed N/A year-over-year to $648000.0; the TTM value through Dec 2019 reached $648000.0, changed N/A, while the annual FY2019 figure was $648000.0, N/A changed from the prior year.
  • Inventory for Q4 2019 was $648000.0 at Ironwood Pharmaceuticals, down from $2.3 million in the prior quarter.
  • Across five years, Inventory topped out at $5.0 million in Q1 2015 and bottomed at $76000.0 in Q3 2018.
  • The 5-year median for Inventory is $1.1 million (2016), against an average of $1.4 million.
  • The largest annual shift saw Inventory tumbled 84.13% in 2018 before it skyrocketed 2923.68% in 2019.
  • A 5-year view of Inventory shows it stood at $5.0 million in 2015, then tumbled by 78.16% to $1.1 million in 2016, then tumbled by 32.01% to $735000.0 in 2017, then tumbled by 89.66% to $76000.0 in 2018, then skyrocketed by 752.63% to $648000.0 in 2019.
  • Per Business Quant, the three most recent readings for IRWD's Inventory are $648000.0 (Q4 2019), $2.3 million (Q3 2019), and $1.7 million (Q2 2019).